Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Buy
60
MDT Quote, Financials, Valuation and Earnings
Last price:
$81.59
Seasonality move
:
2.99%
Day range:
$81.09 - $81.78
52-week range:
$75.96 - $92.68
Dividend yield:
3.42%
P/E ratio:
24.89x
P/S ratio:
3.23x
P/B ratio:
2.15x
Volume:
7.4M
Avg. volume:
6.7M
1-year change:
-0.46%
Market cap:
$104.4B
Revenue:
$32.4B
EPS (TTM):
$3.27
Analysts' Opinion
-
Consensus RatingMedtronic PLC has received a consensus rating of Hold. The company's average rating is a Hold based on 11 Buy ratings, 14 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $96.00, Medtronic PLC has an estimated upside of 17.94% from its current price of $81.54.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $82.00 representing -0.74% downside risk from its current price of $81.54.
Fair Value
-
According to the consensus of 26 analysts, Medtronic PLC has 17.94% upside to fair value with a price target of $96.00 per share.
MDT vs. S&P 500
-
Over the past 5 trading days, Medtronic PLC has underperformed the S&P 500 by -1.65% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Medtronic PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medtronic PLC has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Medtronic PLC reported revenues of $8.4B.
Earnings Growth
-
Medtronic PLC has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Medtronic PLC reported earnings per share of $0.99.
Enterprise value:
124.9B
EV / Invested capital:
1.62x
Price / LTM sales:
3.23x
EV / EBIT:
21.10x
EV / Revenue:
3.78x
PEG ratio (5yr expected):
3.82x
EV / Free cash flow:
22.71x
Price / Operating cash flow:
19.39x
Enterprise value / EBITDA:
14.59x
Gross Profit (TTM):
$21.5B
Return On Assets:
4.76%
Net Income Margin (TTM):
13%
Return On Equity:
8.54%
Return On Invested Capital:
5.61%
Operating Margin:
19.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Income Statement | ||||||
| Revenue | $30.8B | $32B | $33B | $8B | $8.4B | |
| Gross Profit | $20.7B | $20.9B | $21.5B | $5.2B | $5.5B | |
| Operating Income | $6B | $6.1B | $5.7B | $1.4B | $1.6B | |
| EBITDA | $8.9B | $8.8B | $8.6B | $2.2B | $2.4B | |
| Diluted EPS | $3.22 | $3.07 | $3.27 | $0.68 | $0.99 | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $26B | $22.7B | $25.4B | $22.1B | $22.4B | |
| Total Assets | $95.9B | $91.8B | $93.2B | $90.1B | $90B | |
| Current Liabilities | $12.1B | $7.8B | $14.5B | $9.7B | $12.2B | |
| Total Liabilities | $45.6B | $39.6B | $41.2B | $38.4B | $41.3B | |
| Total Equity | $50.3B | $52.2B | $52.1B | $51.6B | $48.7B | |
| Total Debt | $30B | $25.6B | $26.6B | $25B | $28.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $6.3B | $5.6B | $7.2B | $661M | $958M | |
| Cash From Investing | -$2.9B | -$1.7B | -$2B | -$424M | -$345M | |
| Cash From Financing | -$1.1B | -$7.6B | -$5.1B | -$90M | -$534M | |
| Free Cash Flow | $4.8B | $4B | $5.5B | $200M | $554M | |
MDT
Sector
Market Cap
$104.4B
$45.6M
Price % of 52-Week High
87.83%
45.55%
Dividend Yield
3.42%
0%
Shareholder Yield
6.18%
-0.74%
1-Year Price Total Return
-0.64%
-31.35%
Beta (5-Year)
0.820
0.772
Dividend yield:
3.42%
Annualized payout:
$2.76
Payout ratio:
84.54%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$81.15
200-day SMA
Sell
Level
$84.31
Bollinger Bands (100)
Sell
Level
83.69 - 90.35
Chaikin Money Flow
Buy
Level
662.6M
20-day SMA
Sell
Level
$83.33
Relative Strength Index (RSI14)
Sell
Level
35.09
ADX Line
Buy
Level
13
Williams %R
Neutral
Level
-71.5152
50-day SMA
Sell
Level
$86.64
MACD (12, 26)
Sell
Level
-1.63
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Neutral
Level
362.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.781)
Buy
CA Score
(Annual)
Level (0.2368)
Buy
Beneish M-Score
(Annual)
Level (-2.6317)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-2.0959)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
Stock Forecast FAQ
In the current month, MDT has received 11 Buy ratings 14 Hold ratings, and 1 Sell ratings. The MDT average analyst price target in the past 3 months is $96.00.
-
Where Will Medtronic PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medtronic PLC share price will rise to $96.00 per share over the next 12 months.
-
What Do Analysts Say About Medtronic PLC?
Analysts are divided on their view about Medtronic PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Medtronic PLC is a Sell and believe this share price will drop from its current level to $82.00.
-
What Is Medtronic PLC's Price Target?
The price target for Medtronic PLC over the next 1-year time period is forecast to be $96.00 according to 26 Wall Street analysts, 11 of them rate the stock a Buy, 1 rates the stock a Sell, and 14 analysts rate the stock a Hold.
-
Is MDT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medtronic PLC is a Hold. 14 of 26 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MDT?
You can purchase shares of Medtronic PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medtronic PLC shares.
-
What Is The Medtronic PLC Share Price Today?
Medtronic PLC was last trading at $81.59 per share. This represents the most recent stock quote for Medtronic PLC. Yesterday, Medtronic PLC closed at $81.54 per share.
-
How To Buy Medtronic PLC Stock Online?
In order to purchase Medtronic PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
52
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
